Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer’s disease continuum: considerations for clinical trials

Fig. 4

A-B Statistical power as a function of sample size (Aβ + MCI and AD dementia). The minimum required sample size per arm was estimated at 0.05 to 99% power for 1-year (A) and 2-year (B) trial duration. Effect sizes for EEG outcome measures were computed based on significant whole-group LMM results (Table S7, Additional file 2)

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193